None listed
Conditions
Interventions
Drug : This study was conducted in a randomized, open-label, randomized, voluntary consent form for patients with H. pylori infection confirmed by multiplex PCR.
After selection and exclusion criteria
Sponsors
The Catholic University of Korea, Daejeon St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult patients over 18 years of age 2. H. pylori positive by Urea breath test, PCR and CLO test 3. Persons who are approved by the IRB and have written consent prior to participation in the study and are able to comply with clinical trial requirements.
Exclusion criteria
Exclusion criteria: 1. Under 18 years old 2. Persons with disabilities (cognitive disorders, intellectual disabilities) 3. Those who had previous upper gastrointestinal surgery 4. Those who are treated with serious systemic diseases (heart, lung, liver, kidney, coagulation disorder, cancer) 5. Patients who received H.pylori eradication prior to the study 6. Patients who continue to take steroid drugs 5. People who are allergic to antibiotics such as penicillin 6. Patients who received PPI or antibiotics within 4 weeks before the start of eradication therapy 7. Pregnant or lactating 8. An elective suspect, who may be externally influenced by his or her staff or medical students, 9. Patients who refused to sign the consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The frequency and percentage of patients who were successfully treated for eradication at 4 weeks after the eradication treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| side effect, compliance | — |
Countries
Korea, Republic of
Contacts
Public ContactYoung Sin Cho
Soon Chun Hyang University Hospital Cheonan
Outcome results
None listed